Nm23-H1表現之轉錄及表觀遺傳調控機轉研究:抗腫瘤及轉移藥物之Nm23-H1起動子篩選平台應用(2/3)

Medicine & Life Sciences

1. Neoplasm Metastasis 100%
2. Genetic Promoter Regions 93%
3. Methylation 87%
4. Esophageal Neoplasms 66%
5. Tumor Suppressor Genes 63%
6. Epigenomics 56%
7. Lymphatic Metastasis 42%
8. Neoplasms 41%
9. Pharmaceutical Preparations 40%
10. Phenotype 38%
11. Preclinical Drug Evaluations 38%
12. Cell Line 38%
13. Drug Therapy 38%
14. Head and Neck Neoplasms 32%
15. Reporter Genes 32%
16. Liver Neoplasms 32%
17. DNA Methylation 31%
18. Squamous Cell Carcinoma 27%
19. Melanoma 26%
20. Transcription Factors 24%
21. Stomach 23%
22. Clinical Studies 22%
23. Breast Neoplasms 20%
24. Therapeutics 10%